What are the foundation stones laid by Tristel to resume revenue and...

Summary TSTL expects FY21 global sales to remain around £31 million for the year ending on 30 June 2021. The surface disinfectant product sa...

How These 2 Healthcare Stocks Performed Amid Pandemic Challenge

Source: BlurryMe, Shutterstock Summary: UK's leading cell and gene therapy firm Oxford Biomedica reported a 37 per cent increase in its revenue to...

Covid-19 Vaccine Makers in News: J&J, AstraZeneca and Pfizer

Source: insta_photos, Shutterstock Summary J&J delays the distribution of its Covid-19 vaccine to Europe. US may not use the AstraZeneca va...

AstraZeneca’s Farxiga Fails to Yield Statistical Significance for Co...

and concerns of using SGLT2 inhibitors to treat Covid-19 patients admitted to hospital. Things are not at all smooth for the pharma major AstraZe...

EMA Supports Astrazeneca Jabs Despite Links with Rare Blood Clots

Source: LookerStudio, Shutterstock Summary The European Medicines Agency has said that the benefits of using AstraZeneca vaccine outweigh the po...

10 Cheap Healthcare Stocks to Ponder Over This Easter

Source: Guschenkova, Shutterstock Summary On a YTD scale, healthcare stocks have multiplied the investors’ wealth by almost 2.5 times. He...

Moderna vaccine to be rolled out in April as UK aims to vaccinate al...

Source: insta_photos, Shutterstock Summary The UK authorities said that first jabs of Moderna vaccine would be rolled out in April. The Boris J...

Astrazeneca Vaccine Less Effective Than Earlier Touted, Claims Lates...

Source: PhotobyTawat, Shutterstock Summary The Oxford-AstraZeneca vaccine is 76 per cent effective against the coronavirus infection. The earli...

AstraZeneca Shares Making ‘Inverse Head And Shoulders’ Pattern Amid...

Source: PhotobyTawat, Shutterstock Summary Shares of AstraZeneca have experienced a turbulent trading session of late. The stock was trading at...

Vaccine Stocks in Focus as AstraZeneca Awaits EU Verdict on Its Jabs

Source: Aedka Studio, Shutterstock Summary AstraZeneca has recently faced suspensions from several countries and now is awaiting the EU medical...

4 Aspects That Can Decide The Future Of Vaccines

Source: insta_photosy, Shutterstock Summary The future of vaccines will depend on several factors such as efficacy of next-generation vaccines,...

Vaccine stocks in focus as UK rejects EU’s vaccine export ban claims

Source: PalSand, Shutterstock  Summary The British government denied false EU claims over vaccine nationalism concerns. Pandemic seems to...

Why Moderna, Pfizer Et Al Are Poised for Strong Gains in FY 2021

Source: LookerStudio, Shutterstock Summary Several pharmaceutical companies, such as Moderna, Pfizer-BioNTech, Astrazeneca, and others are expec...

3 FTSE 250 healthcare stocks with over 25% return in last one year 

Source: janews, Shutterstock  Summary Three FTSE 250 index stocks have given over 25 per cent return on investment in the last&nb...

Will Moderna’s booster shots be effective on South African variant? 

Source: joel bubble ben, Shutterstock Summary Moderna said that it has been able to produce booster shots particularly for the So...

Avacta (LON: AVCT) Plans Commercial Launch of Lateral Flow Covid-19...

Source: Horth Rasur, Shutterstock Summary Avacta Group is all set to launch its rapid lateral flow Covid test by Q1 2021. The rapid antigen tes...

What are the recent business updates unveiled by LSE listed Clinigen...

Source: Shutterstock Summary Clinigen Group PLC had reported an increase of 4% in net organic revenue during H1 FY21 ended 31 December 2020. CLIN...

Will AstraZeneca meet its EU delivery targets for the second quarter...

  AstraZeneca PLC (LON: AZN) has expressed its disability to deliver the agreed doses of the Covid-19 vaccine to the European Union, b...

How effective is the Pfizer-BioNtech vaccine against the South Afric...

Summary A lab study has found that Pfizer-BioNtech vaccine could be less impactful on South African strain. The vaccine had two-thirds less&n...

How Kanabo will gain from its smashing debut at London Stock Exchang...

Summary Kanabo came up with an IPO on 16 February which was worth 4.75 pence per share. The shares quadrupled in val...